Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons

  1. Disi An
  2. Ryosuke Fujiki
  3. Dylan E Iannitelli
  4. John W Smerdon
  5. Shuvadeep Maity
  6. Matthew F Rose
  7. Alon Gelber
  8. Elizabeth K Wanaselja
  9. Ilona Yagudayeva
  10. Joun Y Lee
  11. Christine Vogel
  12. Hynek Wichterle
  13. Elizabeth C Engle
  14. Esteban Orlando Mazzoni  Is a corresponding author
  1. New York University, United States
  2. Boston Children's Hospital, United States
  3. Columbia University Medical Center, United States
  4. Boston Childrens Hospital, United States

Abstract

In amyotrophic lateral sclerosis (ALS) spinal motor neurons (SpMN) progressively degenerate while a subset of cranial motor neurons (CrMN) are spared until late stages of the disease. Using a rapid and efficient protocol to differentiate mouse embryonic stem cells (ESC) to SpMNs and CrMNs, we now report that ESC-derived CrMNs accumulate less human (h)SOD1 and insoluble p62 than SpMNs over time. ESC-derived CrMNs have higher proteasome activity to degrade misfolded proteins and are intrinsically more resistant to chemically-induced proteostatic stress than SpMNs. Chemical and genetic activation of the proteasome rescues SpMN sensitivity to proteostatic stress. In agreement, the hSOD1 G93A mouse model reveals that ALS-resistant CrMNs accumulate less insoluble hSOD1 and p62-containing inclusions than SpMNs. Primary-derived ALS-resistant CrMNs are also more resistant than SpMNs to proteostatic stress. Thus, an ESC-based platform has identified a superior capacity to maintain a healthy proteome as a possible mechanism to resist ALS-induced neurodegeneration.

Data availability

Sequencing data have been deposited in GEO under accession code GSE130938.

The following data sets were generated

Article and author information

Author details

  1. Disi An

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Ryosuke Fujiki

    Department of Neurology, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Dylan E Iannitelli

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7654-9433
  4. John W Smerdon

    Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Shuvadeep Maity

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6031-4744
  6. Matthew F Rose

    Department of Neurology, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1148-4130
  7. Alon Gelber

    Department of Neurology, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Elizabeth K Wanaselja

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Ilona Yagudayeva

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Joun Y Lee

    Department of Neurology, Boston Children's Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Christine Vogel

    Department of Biology, New York University, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2856-3118
  12. Hynek Wichterle

    Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7817-0080
  13. Elizabeth C Engle

    Department of Neurology, Boston Childrens Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Esteban Orlando Mazzoni

    Department of Biology, New York University, New York, United States
    For correspondence
    eom204@nyu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8994-681X

Funding

PROJECT ALS (A13-0416)

  • Esteban Orlando Mazzoni

Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD079682)

  • Esteban Orlando Mazzoni

NYDH (DOH01-C32243GG-3450000)

  • Esteban Orlando Mazzoni

MODBDF (#5-FY14-99)

  • Esteban Orlando Mazzoni

National Institute of Neurological Disorders and Stroke (F31 NS 095571)

  • John W Smerdon

National Institute of Neurological Disorders and Stroke (F31 103447)

  • Dylan E Iannitelli

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Protocols were approved by Columbia University and Harvard University

Copyright

© 2019, An et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,691
    views
  • 857
    downloads
  • 32
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Disi An
  2. Ryosuke Fujiki
  3. Dylan E Iannitelli
  4. John W Smerdon
  5. Shuvadeep Maity
  6. Matthew F Rose
  7. Alon Gelber
  8. Elizabeth K Wanaselja
  9. Ilona Yagudayeva
  10. Joun Y Lee
  11. Christine Vogel
  12. Hynek Wichterle
  13. Elizabeth C Engle
  14. Esteban Orlando Mazzoni
(2019)
Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons
eLife 8:e44423.
https://doi.org/10.7554/eLife.44423

Share this article

https://doi.org/10.7554/eLife.44423

Further reading

    1. Neuroscience
    William T Redman, Santiago Acosta-Mendoza ... Michael J Goard
    Research Article

    Although grid cells are one of the most well-studied functional classes of neurons in the mammalian brain, whether there is a single orientation and spacing value per grid module has not been carefully tested. We analyze a recent large-scale recording of medial entorhinal cortex to characterize the presence and degree of heterogeneity of grid properties within individual modules. We find evidence for small, but robust, variability and hypothesize that this property of the grid code could enhance the encoding of local spatial information. Performing analysis on synthetic populations of grid cells, where we have complete control over the amount heterogeneity in grid properties, we demonstrate that grid property variability of a similar magnitude to the analyzed data leads to significantly decreased decoding error. This holds even when restricted to activity from a single module. Our results highlight how the heterogeneity of the neural response properties may benefit coding and opens new directions for theoretical and experimental analysis of grid cells.

    1. Genetics and Genomics
    2. Neuroscience
    Monique Marylin Alves de Almeida, Yves De Repentigny ... Rashmi Kothary
    Research Article

    Spinal muscular atrophy (SMA) is caused by mutations in the Survival Motor Neuron 1 (SMN1) gene. While traditionally viewed as a motor neuron disorder, there is involvement of various peripheral organs in SMA. Notably, fatty liver has been observed in SMA mouse models and SMA patients. Nevertheless, it remains unclear whether intrinsic depletion of SMN protein in the liver contributes to pathology in the peripheral or central nervous systems. To address this, we developed a mouse model with a liver-specific depletion of SMN by utilizing an Alb-Cre transgene together with one Smn2B allele and one Smn1 exon 7 allele flanked by loxP sites. Initially, we evaluated phenotypic changes in these mice at postnatal day 19 (P19), when the severe model of SMA, the Smn2B/- mice, exhibit many symptoms of the disease. The liver-specific SMN depletion does not induce motor neuron death, neuromuscular pathology or muscle atrophy, characteristics typically observed in the Smn2B/- mouse at P19. However, mild liver steatosis was observed, although no changes in liver function were detected. Notably, pancreatic alterations resembled that of Smn2B/-mice, with a decrease in insulin-producing β-cells and an increase in glucagon-producingα-cells, accompanied by a reduction in blood glucose and an increase in plasma glucagon and glucagon-like peptide (GLP-1). These changes were transient, as mice at P60 exhibited recovery of liver and pancreatic function. While the mosaic pattern of the Cre-mediated excision precludes definitive conclusions regarding the contribution of liver-specific SMN depletion to overall tissue pathology, our findings highlight an intricate connection between liver function and pancreatic abnormalities in SMA.